New JAK Inhibitor Study Data Confirm Benefit in Alopecia Areata New JAK Inhibitor Study Data Confirm Benefit in Alopecia Areata

The investigational drug deuruxolitinib is effective for hair regrowth in patients with alopecia areata, putting it in line to become second approved JAK inhibitor.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Dermatology News Source Type: news